#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Ovarian cancer Colorectal cancer Hepatocellular carcinoma Asthma Dermatitis atopic Dementia Alzheimer's type Breast cancer metastatic Type 2 diabetes mellitus Non-small cell lung cancer metastatic More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Dermatitis Polymyositis Bronchiectasis Ocular myasthenia Precursor T-lymphoblastic lymphoma/leukaemia recurrent Mantle cell lymphoma Philadelphia positive chronic myeloid leukaemia Hypersomnia Paroxysmal nocturnal haemoglobinuria Angiosarcoma metastatic Cholestatic pruritus Congenital pseudarthrosis Dermatomyositis Biotinidase deficiency Osteomyelitis More trials…

    Learn about Rare Diseases

    Methylmalonic acidaemia – Treatment Brain stem glioma – Treatment Leukoencephalopathy Mucous membrane pemphigoid – Basic Information Sjogren’s syndrome – Trials in Disease Immunodeficiency congenital – Life with Disease VEXAS syndrome – Basic Information Lysosomal storage disorder – Life with Disease Mantle cell lymphoma stage IV – Diagnostics Extranodal marginal zone B-cell lymphoma (MALT type) – Treatment More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Desonide Ly3454738 Ecubectedin ANUMIGILIMAB Palonosetron Hydrochloride Imifoplatin Fenfluramine Hydrochloride Rezpegaldesleukin SGT-003 LIPASE Mbf-015 Pehero Tegafur Cocarboxylase Tetrahydrate Clomifene Citrate SODIUM TETRACHLOROPALLADATE Ciclosporin A Tozorakimab Doxazosin Levomepromazine Hydrochloride More therapies…

    Learn about Your Condition

    Streptococcal infection Osteoporosis Inflammatory bowel disease B-cell lymphoma refractory Viral infection Biliary cancer metastatic Thyroidectomy Transient ischaemic attack Retinitis pigmentosa Infective uveitis Infertility male Pancoast's tumour Soft tissue sarcoma Meniscus injury Cholangitis sclerosing More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. Institut Regional Du Cancer De Montpellier

Institut Regional Du Cancer De Montpellier

208 Avenue Des Apothicaires, Montpellier, 34298, France

Want to learn more about this study or check if you can participate? Contact us.

  • Study of tucatinib, pertuzumab and trastuzumab combination for patients with HER2-positive metastatic breast cancer who have brain metastases after local therapy

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    • HER2 positive breast cancer
    Investigated Drugs:
    • Anastrozole
    • Exemestane
    • Tucatinib
    France

  • Comparing drug combinations with panitumumab for patients with RAS and B-RAF wild-type metastatic colorectal cancer

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    • Colorectal cancer metastatic
    Investigated Drugs:
    • Panitumumab
    • Calcium Levofolinate
    • Folinic Acid
    France

  • Study comparing giredestrant plus palbociclib versus letrozole plus palbociclib in patients with estrogen receptor-positive, HER2-negative advanced or metastatic breast cancer

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Breast cancer metastatic
    Investigated Drugs:
    • Giredestrant
    • Letrozole
    • Palbociclib
    Austria Belgium Denmark France Germany Greece +5

  • Study Comparing Nivolumab, Nivolumab with Ipilimumab, or Chemotherapy for Patients with Metastatic Colorectal Cancer with High Microsatellite Instability

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Colorectal cancer metastatic
    Investigated Drugs:
    • Disodium Folinate
    • Ipilimumab
    • Irinotecan Hydrochloride Trihydrate
    Austria Belgium Czechia Denmark France Germany +6

  • Study of Niraparib and Dostarlimab Combined with Platinum Therapy for Newly Diagnosed Stage III or IV Non-mucinous Epithelial Ovarian Cancer

    Not recruiting

    3 1 1
    Investigated Drugs:
    • Dostarlimab
    • Niraparib Tosilate Monohydrate
    Belgium Czechia Denmark Finland France Germany +7

  • Durvalumab Maintenance Therapy for Frail Patients with Limited Stage Small Cell Lung Cancer After Chemoradiotherapy

    Not recruiting

    2 1 1 1
    Investigated Drugs:
    • Durvalumab
    France

  • Study of Tucatinib, Trastuzumab, and Pertuzumab for Patients with Advanced or Metastatic HER2+ Breast Cancer

    Not recruiting

    3 1 1
    Investigated Drugs:
    • Tucatinib
    • Pertuzumab
    • Trastuzumab
    Austria Belgium Czechia Finland France Germany +6

  • Study of EPI-7386 and Enzalutamide for Patients with Metastatic Castration-Resistant Prostate Cancer

    Not recruiting

    1 1 1 1
    Investigated Diseases:
    • Hormone-refractory prostate cancer
    Investigated Drugs:
    • Masofaniten
    • Enzalutamide
    Belgium France Spain

  • Study on Atezolizumab for Patients with Non-Small Cell Lung Cancer After Chemotherapy

    Not recruiting

    3 1 1 1
    Investigated Drugs:
    • Atezolizumab
    • Cisplatin
    • Docetaxel
    France Germany Hungary Italy The Netherlands Poland +3

  • Study on the Effect of Hyperthermic Intraperitoneal Chemotherapy with Cisplatin for Stage III Ovarian Cancer Patients Undergoing Surgery

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Ovarian cancer stage III
    Investigated Drugs:
    • Sodium Thiosulfate
    • Bevacizumab
    • Carboplatin
    Denmark France Germany Ireland Italy The Netherlands +1
Previous Page
1 … 17 18 19 20 21 … 25
Next Page

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!